Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis01:18

Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis

1.1K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy.

Molecular therapy. Advances·2026
Same author

Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs.

JACC. Basic to translational science·2026
Same author

Extracellular vesicles as double-edged swords: from surgery-induced arrhythmogenesis to therapeutic opportunity.

Cardiovascular research·2025
Same author

Report on the 6th Ottawa International Conference on Neuromuscular Disease & Biology - September 7-9, 2023, Ottawa, Canada.

Journal of neuromuscular diseases·2025
Same author

Extracellular vesicles efficiently deliver survival motor neuron protein to cells in culture.

Scientific reports·2025
Same author

Development and Characterization of an Oncolytic Human Adenovirus-Based Vector Co-Expressing the Adenovirus Death Protein and p14 Fusion-Associated Small Transmembrane Fusogenic Protein.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jun 25, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

683

Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency.

Charlotte A René1,2,3, Robin J Parks1,2,3,4

  • 1Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

Molecular Therapy. Methods & Clinical Development
|May 21, 2024
PubMed
Summary

Extracellular vesicles (EVs) can deliver therapeutic molecules between cells. Researchers are developing methods to improve EV loading for enhanced therapeutic delivery and efficacy.

Keywords:
biodistributionbioengineeringexosomesextracellular vesiclestherapeutic delivery

More Related Videos

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

252
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.1K

Related Experiment Videos

Last Updated: Jun 25, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

683
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

252
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.1K

Area of Science:

  • Biotechnology
  • Cell Biology
  • Nanomedicine

Background:

  • Extracellular vesicles (EVs) are natural carriers of biomolecules, showing promise as drug delivery systems.
  • Enhancing the specific cargo loading into EVs is crucial for improving therapeutic outcomes.
  • Understanding EV biogenesis and cargo selection is key to optimizing their therapeutic potential.

Purpose of the Study:

  • To review the natural biogenesis and cargo selection mechanisms of extracellular vesicles (EVs).
  • To discuss innovative strategies for enhancing the loading of specific therapeutic cargoes into EVs.
  • To summarize the *in vivo* biodistribution of EVs and ongoing clinical trials.

Main Methods:

  • Literature review of EV biogenesis and cargo loading mechanisms.
  • Analysis of novel methods for engineered EV cargo loading.
  • Review of studies on EV biodistribution and clinical applications.

Main Results:

  • EVs naturally transport proteins, lipids, and nucleic acids, making them versatile delivery vehicles.
  • Various strategies exist to enhance the loading efficiency of desired therapeutic molecules into EVs.
  • Ongoing research explores EV biodistribution and clinical efficacy in therapeutic settings.

Conclusions:

  • Optimizing cargo loading into EVs can significantly enhance their therapeutic delivery efficiency.
  • Further research into EV biogenesis and engineering holds promise for advancing nanomedicine.
  • Clinical trials are actively investigating the therapeutic potential of engineered EVs.